Genomic Profiling for Stage II Colon Cancer: Understanding Risk Factors for Recurrence

Description: This is my 5-minute discussion with Timothy Starr, Ph.D, a laboratory-based researcher at the University of Minnesota working on genomic profiling in colorectal cancer. We discuss the state of the field of research into genomic profiling of stage II colon cancers, and factors that determine whether or not chemotherapy treatment is recommended following surgery in patients with these cancers.

Learn more about Dr. Tim Starr and his work on his lab website:
Shared By : cancerassassin1
Posted on : 01/16/15
Added : 5 years ago
Category : Colorectal Cancer